This genetic defect affects approximately 1 in 200 individuals of European origin and impairs the regulation of hepcidin, the principal negative iron-regulatory hormone, resulting in clinically significant iron overload in up to 40% of C282Y homozygous individuals2–4. The gene discussed is HAMP; the disease is Tangier disease.